title: IP3-mediated octopamine-induced synaptic enhancement of crayfish LG neurons.
abstract: The biogenic amines, octopamine and serotonin, modulate the synaptic activity of the lateral giant interneuron (LG) circuitry of the crayfish escape behavior. Bath application of both octopamine and serotonin enhances the synaptic responses of LG to sensory stimulation. We have shown previously (Araki et al. J Neurophysiol 94:2644-2652, 2005) that a serotonin-induced enhancement of the LG response was mediated by an increase in cAMP levels following activation of adenylate cyclase; however, octopamine acts independently. Here, we clarify how octopamine enhances the LG response during sensory stimulation using physiological and pharmacological analyses. When phospholipase C inhibitor U-73122 was directly injected into the LG before biogenic amine application, it abolished the enhancing effect of octopamine on direct sensory input to the LG, but did not block indirect input via sensory interneurons or the effect of serotonin. Direct injection of IP(3), and its analogue adenophostin A, into the LG increased the synaptic response of the LG to sensory stimulation. Thus, IP(3) mediates octopamine-induced synaptic enhancement of the LG, but serotonin acts independently. These results indicate that both octopamine and serotonin enhance the synaptic responses of the LG to sensory stimulation, but that they activate two different signaling cascades in the LG.
authors.affiliation: Division of Biological Sciences, Graduate School of Science, Hokkaido University, Sapporo, 060-0810, Japan.
authors.forename: Makoto
authors.initials: M
authors.lastname: Araki
authors.forename: Toshiki
authors.initials: T
authors.lastname: Nagayama
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D003400:Astacoidea / Q000187:drug effects / Q000378:metabolism*; D004558:Electric Stimulation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004963:Estrenes / Q000494:pharmacology; D005260:Female; D017952:Ganglia, Invertebrate / Q000187:drug effects / Q000378:metabolism*; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism*; D053496:Inositol 1,4,5-Trisphosphate Receptors / Q000187:drug effects / Q000378:metabolism; D007395:Interneurons / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009655:Octopamine / Q000378:metabolism*; D011760:Pyrrolidinones / Q000494:pharmacology; D012677:Sensation / Q000187:drug effects; D012684:Sensory Thresholds; D012701:Serotonin / Q000378:metabolism; D055366:Synaptic Potentials; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D004963:Estrenes; D053496:Inositol 1,4,5-Trisphosphate Receptors; D011760:Pyrrolidinones; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; C085029:adenophostin A; D009655:Octopamine; D012701:Serotonin; D015544:Inositol 1,4,5-Trisphosphate; D010738:Type C Phospholipases; D000241:Adenosine